Clinical Trial Update: PROMINENT-Eye Ancillary Study (Protocol AD) [Phase 3]

View source ↗

Summary

A Phase 3 ancillary study (PROMINENT-Eye) for diabetic retinopathy and diabetic macular edema has been terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Status: TERMINATED | Results posted: 2020-09-16